Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
2(13%)
Results Posted
9%(1 trials)

Phase Distribution

Ph not_applicable
14
93%
Ph phase_3
1
7%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution15 total trials
Phase 3Large-scale testing
1(6.7%)
N/ANon-phased studies
14(93.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

15

all time

Status Distribution
Active(2)
Completed(11)
Other(2)

Detailed Status

Completed11
unknown2
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (6.7%)
N/A14 (93.3%)

Trials by Status

unknown213%
active_not_recruiting17%
recruiting17%
completed1173%

Recent Activity

Clinical Trials (15)

Showing 15 of 15 trials

All 15 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
15